Abbott to pay $670 million to settle some preterm infant formula cases | Reuters

Part of story

Abbott Laboratories to pay $670 million to settle preterm infant formula lawsuits

Abbott agreed to pay $670 million to settle lawsuits alleging it concealed risks that its preterm infant formula can cause necrotizing enterocolitis, a deadly bowel disease in premature babies.

Aug 20, 20262 sourcesCorporate accountability

Abbott Laboratories to pay $670 million to settle preterm infant formula lawsuits

Other sources for this story

Bloomberg

Abbott Laboratories to Pay $670 Million in Preemie Formula Disease Claims

Featured Stories

CIA Director John Ratcliffe arrives in Moscow aboard US military plane for meetings

Aug 25, 20268 sources